We came across a bullish thesis on Vera Therapeutics, Inc. on Valueinvestorsclub.com by yarak775. In this article, we will summarize the bulls’ thesis on VERA. Vera Therapeutics, Inc.’s share was trading at $45.11 as of January 28th.
Pressmaster/Shutterstock.com
Vera Therapeutics (VERA) is a clinical-stage biotechnology company focused on developing biologic therapies for autoimmune diseases, with its investment case centered almost entirely on a single, highly de-risked asset:...
